SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
New insights into COVID-19 infectiousness
Fri August 19th - British researchers have unveiled the first real-world study to estimate how long people are infectious with mild COVID-19. More
Gene variant that protects against heart disease
Fri August 19th - A gene variant has been identified that helps to protect against heart diseases. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Low heart risk from COVID jab

Wednesday April 13th 2022

There is no significant rise in cases of myopericarditis after COVID-19 vaccination programmes, according to a new analysis.

There have been reports of myopericarditis after COVID jabs, particularly in adolescents and young adults, so researchers from National University of Singapore set out to examine the rate internationally.

They analysed the evidence from 22 studies covering 405,272,721 vaccine doses. This showed an overall myopericarditis rate of 33.3 cases per million vaccine doses.

In *The Lancet Respiratory Medicine* the team explain that this "did not differ significantly between people who received COVID-19 vaccines and those who received non-COVID-19 vaccines".

The rate of myopericarditis was the same for people given the COVID jab and a flu jab, whereas the rate was higher for people given a smallpox vaccination.

Among those who received a COVID jab, myopericarditis was more likely for men, and people below 30 years. It was also higher for those given an mRNA versus non-mRNA vaccine, and after a second dose, versus first or third dose.

Dr Kollengode Ramanathan of the National University Hospital, Singapore, and colleagues write: "The overall risk of myopericarditis after receiving a COVID-19 vaccine is low.

"However, younger males have an increased incidence of myopericarditis, particularly after receiving mRNA vaccines.

"Nevertheless, the risks of such rare adverse events should be balanced against the risks of COVID-19 infection, including myopericarditis."

Dr Ramanathan commented: “These findings should bolster public confidence in the safety of COVID-19 vaccinations.”

Ling, R. R. et al. Myopericarditis following COVID-19 vaccination and nonCOVID-19 vaccination: a systematic review and metaanalysis. *Lancet Respiratory Medicine* 11 April 2022; doi: 10.1016/S2213-2600(22)00059-5

[abstract]

Tags: Asia | Flu & Viruses | Heart Health | Pharmaceuticals | Respiratory | World Health

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES